Optics.org
daily coverage of the optics & photonics industry and the markets that it serves
Featured Showcases
Photonics West Showcase
Optics+Photonics Showcase
Press Releases
Menu
Press Release

Bruker Completes Acquisition of the Atomic Force Microscopy and Optical Industrial Metrology Instruments Businesses from Veeco

Date Announced: 07 Oct 2010

Previously announced deal is completed for $229.4M in cash.

BILLERICA, Mass.--(BUSINESS WIRE)-- Bruker Corporation (NASDAQ:BRKR - News) today announced the closing of its acquisition of the Atomic Force Microscopy (AFM) and the Optical Industrial Metrology (OIM) instruments businesses from Veeco Instruments, Inc. (NASDAQ:VECO - News) for $229.4 million in cash.

The industry-leading AFM scientific instruments business headquartered in Santa Barbara, California, as well as the OIM business based in Tucson, Arizona, along with the global AFM/OIM field sales, applications and support organizations, have now become part of the Bruker Nano Division, which is part of the Bruker AXS Group, adding more than 350 employees in eleven countries. The 2009 revenues for the AFM and OIM instruments businesses were derived approximately 38% from Asia-Pacific, 31% from the Americas, and 31% from Europe, and in terms of customers approximately 45% from applied/industrial customers and 55% from academic/government customers.

The acquired AFM and OIM businesses are highly complementary to Bruker’s existing systems and solutions, and the combined product portfolio transforms Bruker into a global leader in materials research and nanotechnology analysis instrumentation. In addition to the newly acquired AFM and OIM product lines, Bruker offers a broad range of high-performance X-Ray Diffraction (XRD), X-Ray Fluorescence (XRF), XRF microanalysis (μXRF), vibrational spectroscopy (FTIR, NIR, Raman) and AFM hybrid (e.g. AFM-Raman, AFM-optical microscopy) systems, as well as EDS and EBSD analyzer accessories for third-party electron microscopes, all used for surface analysis in materials, life-science and nanotechnology R&D and quality control.

Bruker has long been a global leader in life-science research tools with a focused portfolio of high-performance NMR, pre-clinical MRI, EPR, life-science mass spectrometry and X-ray crystallography instruments. In May 2010, Bruker also expanded its mass spectrometry portfolio into the chemical analysis markets with the acquisition of laboratory GC, GC-MS/MS and ICP-MS product lines of Varian Inc.

Frank Laukien, President and CEO of Bruker Corporation, stated: "We are very excited about the addition of these highly regarded AFM and OIM businesses to Bruker, as they complement our focused product and market strategies very well. With these additional high-performance and industry-leading products, Bruker can now serve its global customers and markets even better. Moreover, we cordially welcome the many talented and motivated new AFM and OIM colleagues who have just joined Bruker."

Mark R. Munch, Ph.D., previously the Executive Vice President of Veeco’s Metrology and Instrumentation Business, has been appointed President of Bruker Nano, Inc. with responsibility for the acquired AFM and OIM businesses. Dr. Munch received his Ph.D. in Chemical Engineering from Stanford University. He has been the Veeco Executive Vice President, Metrology and Instrumentation since February 2008. From 2006 to 2008, he was Senior Vice President and General Manager of the Commercial Lasers and Components Group of Coherent Inc. From 2004 to 2006, Dr. Munch was Chief Executive Officer and President of Cooligy Inc. Prior to that, he held a number of executive and general management positions at Corning Inc., Tyco Electronics Corporation, and Raychem Corporation.

Dr. Munch commented: “Together with Bruker, we now have a tremendous new ability to further develop innovative products that will evolve the industry and how we measure and obtain nanoscale information. Bruker has been extremely supportive from the start and is dedicated to ensuring that our current and future customers receive the highest performing and most innovative instruments with unsurpassed service.”

Financial Outlook for Acquired Bruker Nano AFM and OIM Businesses
Bruker expects the newly acquired businesses to contribute approximately $20 million of revenue in the fourth quarter of 2010. AFM and OIM revenues in the fourth quarter of 2010 will be significantly lower than recent quarterly averages due to the planned implementation of Bruker’s revenue recognition policy, where most systems will be recognized as revenue upon signed customer acceptance. The implementation of this revenue recognition policy will cause a one-time delay in AFM and OIM revenues in the fourth quarter of 2010, and is also expected to increase backlog at year-end compared to historical balances. Accordingly, in the fourth quarter of 2010, Bruker expects the AFM and OIM businesses to generate a GAAP operating loss of $6.5-$7.5 million, and a GAAP loss per share of $0.04-$0.05, primarily due to this one-time shift in revenue recognition. Included in these fourth quarter 2010 GAAP estimates are acquisition-related charges of approximately $0.6 million for transitional services provided to Bruker, approximately $1.5 million associated with the required step-up of acquired inventory and fixed assets, as well as a non-cash charge of approximately $1.7 million for amortization of acquisition-related intangible assets, for a combined AFM/OIM acquisition-related charge of approximately $3.8 million in the fourth quarter of 2010.

In 2011, the acquired Bruker Nano AFM and OIM businesses are forecasted to contribute revenues greater than $130 million, and adjusted operating margins (excluding acquisition-related and non-cash intangible amortization charges) of greater than 15%. In 2011, Bruker expects to incur additional AFM/OIM acquisition-related charges of approximately $1.0 million, and approximately $7.0 million of non-cash charges associated with the amortization of acquisition-related intangible assets, based on a preliminary purchase price allocation. The overall effect is expected to result in the new AFM and OIM businesses being approximately two to four cents accretive to Bruker’s 2011 GAAP EPS, and six to eight cents accretive to 2011 adjusted EPS.

Source: Bruker

Contact

Stacey Desrochers
Bruker Director of Investor Relations
T: 978-663-3660, ext. 1115

E-mail: stacey.desrochers@bruker.com

Web Site: www.bruker.com

© 2024 SPIE Europe
Top of Page